1 / 30

Therapy ulcer

Therapy ulcer. of peptic. Peptic ulcer. defects of mucosa of the stomach / duodenum = mucosal damage through the lamina muscularis mucosae Clinical presentation : stomach – pain in the epigastrium shortly after meal (the patient often looses weight), nausea, anorexia

ranger
Download Presentation

Therapy ulcer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Therapy ulcer of peptic

  2. Peptic ulcer • defects of mucosa of the stomach / duodenum = mucosal damage through the lamina muscularis mucosae Clinical presentation: stomach – pain in the epigastrium shortly after meal (the patient often looses weight), nausea, anorexia duodenum – pain later after meal (fasting), often during the night, gets better after eating, the patient can gain weight

  3. Etiopatogenesis imbalance: aggressive factors ↔ protective factors mostly- HCl, pepsin production ↑ - histamine, acetylcholine, gastrin, etc. mostly- mucus, bicarbonate, fast regeneration of the mucosa, adequate perfusion of the gastric wall protective factors ↑ - mostly the production of prostaglandins by cyklooxygenase

  4. Etiopatogenesis - causes • Helicobacter pylori (Hp) • drugs- most frequently NSAIDs, then corticoids etc. • smoking • dietary mistakes (questionable) • psychosocial stress • genetical factors • conditions with shock, burns, head traumas • Zollinger- Ellison sy. • ..........

  5. Diagnosis and Nonpharmacologic treatment • ezophagogastroduodenoscopia histologic check of nature of the ulcer lesions presence of Hp= microscopyhisto-morfology rapid urease testbreath test testing of Ab (in plasma and in stool) • nonpharmacol. therapy: lifestyle (sleep, ↓ stress)diet (often in smaller amounts, ↓ spicy, ↓ caffeine) no smoking

  6. Peptic ulcer in the stomach

  7. Peptic ulcer in the duodenum

  8. Peptic ulcer in the duodenum

  9. Helicobacter pylori – black bacteria on the surface of the gastric mucosa

  10. Pharmacotherapy of peptic ulcer

  11. Antisecretorydrugs (↓ productionofHCl): protonpumpinhibitors(PPI)- omeprazole H2receptor antagonists- famotidine anticholinergics (Pslytics)- pirenzepine DrugsneutralisingHCl: coloidalantacids- compoundsofAl a Mg reactiveantacids- NaHCO3 a CaCO3 Mucoprotectives: prostaglandines, sucralfate, compoundsofbismuth ATBs: amoxicillin, claritromycin, metronidazole, doxycycline; in caseoffailureoftherapy- levofloxacin, rifabutin

  12. Antisecretory drugs(↓ production of HCl)

  13. Proton pump inhibitors • MA – irreversible blockade of H/K-ATPase(proton pump) • most effective antisecretory drugs (inhibit the last phase of HCl secretion → effect independent from the stimulus for HCl secretion) • elevated pH in the stomach decreases the conversion - pepsinogen → pepsin • “prodrugs“ - converted into active metabolite in the parietal cells of gastric mucosa • good safety profile, good tolerance • basic pharmacotherapy for peptic ulcer

  14. Proton pump inhibitors omeprazole:nearlycompleteblockadeofHClsecretionat rest and afterstimulus, hightherapeuticeffectivity druginteractions: diazepam, phenytoin, warfarinclopidogrel??- somestudies- might ↓ effectivityofclopidogrelbecauseofinhibitionof CYP450- administerratherpantoprazole pantoprazole, lanzoprazole: lessinteractions, suitable in polymorbid and olderpatientsesomeprazole:inovatedomeprazolewithfasteronset and longerdurationofactionNewerdrugs: ilaprazol tenatoprazol:strongesteffect, longestdurationofeffect

  15. H2 receptor antagonists • MA - selective blockade of H2 histamine receptors → inhibition of histamine mediated HCl production (indirect effect on secretion mediated by Ach and gastrin) • ↓ effectivity than proton pump inhibitors Examples – cimetidine, ranitidine, famotidine (more effective), nizatidine - good safety profile, good tolerance - drugs of 2nd choice for treatment of peptic ulcer; loosing therapeutic role in most indications (↓ effectivity)

  16. Anticholinergics • MA – inhibition of M1 receptors → inhibition of acetylcholine mediated HCl production • ≈ same effectivity as H2 antagonists • ADRs – consequences of ↓activity of PS – for example dry mouth, problems with vision and urination, constipation • example- pirenzepine - they lost their therapeutic role – ADRs, ↓ effectivity than proton pump inhibitors

  17. Drugs neutralising HCl:(antacids)

  18. coloidal antacids: aluminum and magnesiumhydroxide MA: weak bases → bind HCl; slightly ↑ the production of prostaglandines ADRs: - Al hydroxide: constipation, ↓ resorption of phosphates → osteomalacia; - Mg hydroxide: diarrhoea, hypermagnesemia; both- risk of interactions!! • reactive antacids: NaHCO3and CaCO3 MA: reaction with HCl, during which CO2 is formed ADRs: - flatulence, ´milk-alkali´ syndrome (hypercalcemia, nephrolithiasis, renal insufficiency, ...), in the case of NaHCO3 metabolic alkalosis !!!! Antacids – only for symptomatic treatment of dyspepsia!!!

  19. Mucoprotectives

  20. Prostaglandines • misoprostol (analog of PGE1), enprostil (analog of PGE2) - cytoprotective and mucoprotective effect - improve the microcirculation underneath the mucosa + ↑ production of mucus and bicarbonate + ↑ regenerationof defects ADRs – diarrhoea, stomach pain, abortion, - can be used in prevention of peptic ulcer formation during NSAID treatment (for that, we have other, in most cases better alternatives)

  21. Sucralfate • salt of sulfonated sucrose • MA: in an acidic environment it forms a protective layer on the surface of the mucus membrane and on the surface of the defect • probably stimulates the formation of prostaglandines • well tolerated • !don´t administer after administration of antisecretory drugs! • seldomly used

  22. Bismuth • ↑secretionofmucus and bicarbonate, ↓ secretionofHCl, antibacterialeffect • ADRs – metallic taste in themouth, blacktongue and stool, !neurotoxicity (confusion, hallucinations...) nowadaysusedlessfrequently (risk ofADRs), part of 2nd lineof H. pylorieradicationtherapy

  23. Eradication of Helicobacter pylori (needed for long-term success of pharmacotherapy of peptic ulcer in Hp positive patients)

  24. 1st linetreatment: triple therapy 7 or14 daytreatment (14 days – betterresults) • protonpumpinhibitor • claritromycin • amoxicillin– if PNC allergy - metronidazole problem – decreasingeffectivityofthetreatment (fails in approximately 25-30 % of patients)

  25. 2nd linetreatment: quadrupletherapy (in caseoffailureoftripletherapy; in patientstreatedwithmacrolidesinthepast; canbeconsidered in patientswith PNC allergy) 7 or14 daytreatment (14 days – betterresults) • protonpumpinhibitor • bismuth • metronidazole • doxycycline problem – decreasingeffectivityofthetreatment – possibilityof ↓ compliance(dosingscheme) – ADRs (mostlybismuth)

  26. New possibilities: sequentialtherapy 10 days (5 + 5), forexample: First 5 days • protonpumpinhibitor • amoxicillin Next 5 days • protonpumpinhibitor • claritromycin • tinidazole(possiblymetronidazole??)

  27. Failure of the therapy: Future?? :

  28. Non-steroidal anti-inflammatory drugs (NSAIDs) and peptic ulcer NSAIDs– one of the most widely used drug groups – in roughly 25 % of chronic users can cause erosions and ulcerations in the GIT, in 2-4 % perforation or bleeding Possibilities of prevention– proton pump inhibitors or misoprostol during NSAID treatment; use of NSAIDs selectively inhibiting COX-2 Strategy – small risk of ulcer – NSAID on its own – moderate risk of ulcer – NSAID + PPI / misoprostol – high risk of ulcer – a) administer other (non-NSAID) analgesics, or b) COX-2 selectiveNSAID + PPI / misoprostol

More Related